Published in Health Insurance Week, July 23rd, 2006
Synera is the first topical patch approved for the prevention of pain associated with superficial venous access and superficial dermatological procedures in patients 4 months of age and older. Endo is marketing the Synera patch through its existing 70-person hospital sales force. ZARS Pharma licensed the North American sales and marketing rights to Endo earlier this year.
Synera addresses an important need in the area of topical pain management, particularly in children. According to published data, children under...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.